Buy the Dip Monday: The 5× Earnings Chip Stock Analysts Say Will Rise Ten-Fold

This Week's Setup

The value screen is pricing a semiconductor equipment supplier at 5× earnings with a 15.8% FCF yield and a 40% drawdown while analysts see the stock ten-fold higher from current levels.

A media company carries a 36% FCF yield at 6.8× earnings with ten insider buys in the last six months, zero sells, and analysts projecting 23% upside.

A natural gas producer trades at 10.3× earnings with revenue climbing 60% year over year and a 20% drawdown, while an online education provider sits in a 49% drawdown with a 10.7% FCF yield and 38% analyst upside.

Quick Scan

The 8 Names

1. KLA Corporation (KLAC)

P/E: 5.14 | Earnings yield: 19.5% | 52w drawdown: -41.0%

The setup here is a semiconductor equipment maker trading at 5.1× earnings with a 15.8% FCF yield and a 19.5% earnings yield, pricing a 66% ROIC business as if capital intensity disappeared. Revenue climbed 24% year over year, gross margin sits at 61%, and the market is valuing peak-cycle earnings at a discount to trough multiples.

Analysts see $1,855 from $181 today, a 922% implied upside that reads as a data error or a stale consensus target that hasn't reset to the current price. The 43.5× EV/EBITDA and 101× normalized P/E point to either a recent earnings collapse or a balance sheet restructuring that the trailing data hasn't captured.

The 41% drawdown and absence of insider buying in the last six months signal management sees no floor here. Short interest at 2.6% of float is unremarkable, and debt-to-equity of 1.31 limits buyback firepower if the revenue cycle turns.

2. Amalgamated Financial Corp. (AMAL)

P/E: 13.92 | Earnings yield: 7.2% | 52w drawdown: -7.2%

A regional bank trades at 13.9× earnings with a 9.4% FCF yield and a 1.3% dividend yield, covering the payout 7× out of free cash flow. Revenue growth of 4.4% year over year and a 2.2% earnings yield spread over a normalized 10-year cycle give the setup a margin of safety against rate volatility.

The 7.2% drawdown is shallow for this screen, and the stock trades near its 52-week high, not at a margin of safety entry. Normalized P/E of 15.7× over ten years is above the current trailing multiple, signaling earnings may have run ahead of the long-term mean.

CFO sold nearly 20,000 shares for over $960,000 in September, and three insiders filed Form 4 sales between September 10 and 11. Net insider activity over six months is negative 1,360 shares, all sells, and insider ownership shows zero conviction at current prices.

3. Versant Media (MS NOW) (VSNT)

P/E: 6.82 | Earnings yield: 14.7% | 52w drawdown: -37.0%

The media company carries a 36% FCF yield at 6.8× earnings and a 14.7% earnings yield, pricing the business as if cash generation stops next quarter. The 0.64 price-to-book and 3.2× EV/EBITDA are distressed-asset multiples for a company with 56% gross margin and a 9.7% long-cycle earnings yield.

Ten insider buys in the last six months, zero sells, added 13,500 net shares while the stock dropped 37% from its 52-week high. World Team Tennis announced a broadcast partnership with Versant's USA Sports in August, and the company is presenting at the Goldman Sachs Communacopia conference in September.

Revenue declined 5.3% year over year, and ROIC of 8.2% is below the cost of capital for a levered media business. The 4% dividend yield at a 36% FCF yield suggests capital allocation is defensive, not growth-oriented, and analysts see 23% upside to $45.67, not a step-change revaluation.

4. EQT Corporation (EQT)

P/E: 10.32 | Earnings yield: 9.7% | 52w drawdown: -20.3%

The natural gas producer trades at 10.3× earnings with an 8.3% FCF yield and revenue up 60% year over year, pricing flat production into a rising-price environment. The 9.2% ROIC and 46% gross margin reflect operating leverage from scale, and the 5.7× EV/EBITDA is a third of the peer group median for integrated producers.

The 20% drawdown is the shallowest on this screen, and the stock trades near trend, not at a margin-of-safety entry. Normalized P/E of 17.8× over ten years is 73% above the current trailing multiple, signaling earnings volatility makes the current print an outlier, not a base case.

CEO Toby Z. Rice filed a Form 4 transaction on August 18, the only insider activity in six months. Analysts see $70 from $54 today, a 29% implied upside that prices normalized gas prices and no multiple expansion.

5. GSK plc (GSK)

P/E: 12.54 | Earnings yield: 8.0% | 52w drawdown: -22.1%

The pharma trades at 12.5× earnings with a 20% ROIC, a 72% gross margin, and a 4.9% FCF yield, pricing a 4.1% revenue growth rate as peak cycle. The 3.8% dividend yield and 1.4% shareholder yield reflect a capital return framework that returns half of free cash flow while reinvesting in the pipeline.

The £1.9 billion cost-savings program announced in September is a response to the HIV patent cliff, not a margin expansion opportunity. The 18.7× EV/EBITDA and 1.17 debt-to-equity ratio limit buyback capacity, and the 0.3% short interest signals no crowded short thesis to unwind.

Analysts see $58 from $48 today, a 21% implied upside that assumes the savings program offsets patent expiries and biosimilar competition. The 22% drawdown is moderate for this screen, and the stock trades in line with its long-term trend, not at a distressed entry.